These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12351463

  • 1. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes.
    Strowig SM, Avilés-Santa ML, Raskin P.
    Diabetes Care; 2002 Oct; 25(10):1691-8. PubMed ID: 12351463
    [Abstract] [Full Text] [Related]

  • 2. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.
    Gavin LA, Barth J, Arnold D, Shaw R.
    Endocr Pract; 2000 Dec; 6(4):305-10. PubMed ID: 11242607
    [Abstract] [Full Text] [Related]

  • 4. Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.
    Hershon KS, Hershon PM.
    Endocr Pract; 2000 Dec; 6(1):20-5. PubMed ID: 11419922
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.
    Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.
    Diabetes Care; 2002 Mar; 25(3):542-9. PubMed ID: 11874944
    [Abstract] [Full Text] [Related]

  • 6. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.
    Ann Intern Med; 2001 May 01; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.
    Fonseca V, Foyt HL, Shen K, Whitcomb R.
    Diabetes Care; 2000 Mar 01; 23(3):354-9. PubMed ID: 10868865
    [Abstract] [Full Text] [Related]

  • 8. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
    Blonde L, Sandberg MI, Guthrie RD.
    Diabetes Care; 1999 Jun 01; 22(6):1004-6. PubMed ID: 10372262
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of troglitazone on body fat distribution in type 2 diabetes.
    Akazawa S, Sun F, Ito M, Kawasaki E, Eguchi K.
    Diabetes Care; 2000 Aug 01; 23(8):1067-71. PubMed ID: 10937499
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects.
    Kim YB, Ciaraldi TP, Kong A, Kim D, Chu N, Mohideen P, Mudaliar S, Henry RR, Kahn BB.
    Diabetes; 2002 Feb 01; 51(2):443-8. PubMed ID: 11812753
    [Abstract] [Full Text] [Related]

  • 11. Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.
    Raskin P, Jovanovic L, Berger S, Schwartz S, Woo V, Ratner R.
    Diabetes Care; 2000 Jul 01; 23(7):979-83. PubMed ID: 10895850
    [Abstract] [Full Text] [Related]

  • 12. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
    Imano E, Kanda T, Nakatani Y, Nishida T, Arai K, Motomura M, Kajimoto Y, Yamasaki Y, Hori M.
    Diabetes Care; 1998 Dec 01; 21(12):2135-9. PubMed ID: 9839106
    [Abstract] [Full Text] [Related]

  • 13. Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.
    Horton ES, Whitehouse F, Ghazzi MN, Venable TC, Whitcomb RW.
    Diabetes Care; 1998 Sep 01; 21(9):1462-9. PubMed ID: 9727892
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI.
    N Engl J Med; 1998 Mar 26; 338(13):867-72. PubMed ID: 9516221
    [Abstract] [Full Text] [Related]

  • 15. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.
    Ciaraldi TP, Kong AP, Chu NV, Kim DD, Baxi S, Loviscach M, Plodkowski R, Reitz R, Caulfield M, Mudaliar S, Henry RR.
    Diabetes; 2002 Jan 26; 51(1):30-6. PubMed ID: 11756319
    [Abstract] [Full Text] [Related]

  • 16. Improved glycemic control without weight gain using triple therapy in type 2 diabetes.
    Strowig SM, Avilés-Santa ML, Raskin P.
    Diabetes Care; 2004 Jul 26; 27(7):1577-83. PubMed ID: 15220231
    [Abstract] [Full Text] [Related]

  • 17. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone.
    Khan MA, St Peter JV, Xue JL.
    Diabetes Care; 2002 Apr 26; 25(4):708-11. PubMed ID: 11919129
    [Abstract] [Full Text] [Related]

  • 18. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.
    Schwartz S, Raskin P, Fonseca V, Graveline JF.
    N Engl J Med; 1998 Mar 26; 338(13):861-6. PubMed ID: 9516220
    [Abstract] [Full Text] [Related]

  • 19. Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy.
    Miles JM, Wooldridge D, Grellner WJ, Windsor S, Isley WL, Klein S, Harris WS.
    Diabetes; 2003 Mar 26; 52(3):675-81. PubMed ID: 12606508
    [Abstract] [Full Text] [Related]

  • 20. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI.
    Ann Intern Med; 1998 Feb 01; 128(3):176-85. PubMed ID: 9454525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.